|67.61||-0.21 / -0.31%|
Data as of 4:00pm ET
|67.61||-0.0017 / -0.00%|
The 12 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 53.00, with a high estimate of 91.00 and a low estimate of 40.00. The median estimate represents a -21.61% decrease from the last price of 67.61.
The current consensus among 16 polled investment analysts is to Hold stock in United Therapeutics Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.